Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
bactrim 40 mg/ ml / 8 mg/ ml
eumedica pharmaceuticals gmbh - sulfametoksazol / trimetoprim - mikstur, suspensjon - 40 mg/ ml / 8 mg/ ml
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
bactrim 400 mg / 80 mg
eumedica pharmaceuticals gmbh - sulfametoksazol / trimetoprim - tablett - 400 mg / 80 mg
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
methofill 50 mg/ ml
accord healthcare b.v. - metotreksatdinatrium - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 50 mg/ ml
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
zestoretic 20 mg / 12.5 mg
atnahs pharma netherlands b.v. - lisinoprildihydrat / hydroklortiazid - tablett - 20 mg / 12.5 mg
Ευρωπαϊκή Ένωση -
Νορβηγικά -
EMA (European Medicines Agency)
onsenal
pfizer limited - celecoxib - adenomatøs polyposis coli - antineoplastiske midler - onsenal er indikert for reduksjon av antall adenomatøse intestinale polypper i familiær adenomatøs polyposis (fap), som et tillegg til kirurgi og ytterligere endoskopisk overvåking (se avsnitt 4. effekten av onsenal-indusert reduksjon av polypper byrde på risikoen for tarm kreft har ikke blitt påvist (se kapittel 4. 4 og 5.
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
methotrexate pfizer 25 mg/ ml
pfizer as - metotreksat - injeksjons-/infusjonsvæske, oppløsning - 25 mg/ ml
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
methotrexate pfizer 2.5 mg
pfizer as - metotreksat - tablett - 2.5 mg
Ευρωπαϊκή Ένωση -
Νορβηγικά -
EMA (European Medicines Agency)
nordimet
nordic group b.v. - methotrexate - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastiske midler - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
methotrexate orion 25 mg/ ml
orion corporation - espoo - metotreksat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 25 mg/ ml
Νορβηγία -
Νορβηγικά -
Statens legemiddelverk
ebetrex 100 mg/ ml
ebewe pharma ges.m.b.h nfg. kg - metotreksatdinatrium - konsentrat til infusjonsvæske, oppløsning - 100 mg/ ml